Recent Acquisition MercachemSyncom recently acquired Admescope Ltd, expanding its service offerings and potentially creating opportunities for cross-selling services to a broader client base.
Broad Service Portfolio With over 500 scientists and solutions spanning drug discovery to early clinical drug substance API delivery, MercachemSyncom offers a comprehensive service portfolio that can cater to a wide range of pharmaceutical clients' needs, presenting diverse sales opportunities.
Mid-sized European CRO As a leading mid-sized European Contract Research Organization, MercachemSyncom positions itself as a strong player in the pharmaceutical manufacturing industry, offering a balance of expertise and agility that can appeal to clients seeking personalized services and innovative solutions.
Competitive Landscape While operating in a competitive landscape with companies like GenScript, WuXi AppTec, and Evotec, MercachemSyncom's focus on scientific knowledge and inventiveness sets it apart, providing a unique value proposition that can attract discerning clients looking for cutting-edge drug discovery solutions.
Geographic Reach Located in Nijmegen, Netherlands, MercachemSyncom's strategic location in Europe, where the pharmaceutical sector is robust, can serve as a gateway to engaging with local and international pharmaceutical companies, leveraging regional networks and collaborations for enhanced sales prospects.